E156 Micro-Paper · Africa Clinical Trials

Mental Health Invisibility

Mental health disorders affect an estimated 100 million Africans, but mental hea...

Africa Trials
145
US Trials
9,503
Gap Ratio
66x
Nations
54
Africa hosted 145 depression trials versus 9,503 in the United States, a 66-fold disparity in research investment.
Mental Health Invisibility Lorenz Curve 0% 0% 25% 25% 50% 50% 75% 75% 100% 100% Gini = 0.711
Mental Health Invisibility by Country Egypt: 11752 Algeria: N/A Morocco: 162 Tunisia: 540 Senegal: N/A Ghana: 261 Nigeria: 379 Cameroon: N/A DRC: N/A Ethiopia: 302 Kenya: 788 Uganda: 809 Tanzania: 460 Rwanda: N/A South Africa: 3654 Egy 11752 Sou 3654 Uga 809 Ken 788 Tun 540 162 11752
Enrollment Distribution Africa Reference 2000 4000 6000 8000 10000
Phase Distribution Africa US Europe Phase 1 4 28.8 37.2 Phase 2 14 99.9 134.7 Phase 3 41 263.0 180.8 Phase 4 9 114.2 58.7 263.0 4
No data
Research Profile Volume Growth Phase3 Complete Diversity
Contribution Breakdown 11752 Egypt 3654 South Afri 809 Uganda 788 Kenya 540 Tunisia 2814 Others
Enrollment Density Africa Reference 5000 10000 15000
Why It Matters

Mental health disorders affect an estimated 100 million Africans, but mental health trial investment is among the lowest of any disease category, reflecting persistent stigma and health system neglect.

In the burden-versus-investment landscape of African health research, does the distribution of depression trials across African nations reveal a systematic research gap? This cross-sectional audit evaluated 23,873 African and 190,644 United States interventional trials registered on ClinicalTrials.gov through April 2026. Investigators computed the Shannon entropy of trial allocation as the primary estimand using registry metadata for each nation. Africa hosted 145 depression trials (0.6% of its portfolio) compared to 9,503 in the United States, yielding a 0.0-fold disparity in per-population investment. Shannon entropy of the trial distribution was 2.46 bits, confirming substantial concentration beyond random variation. These results expose a fundamental mismatch between where disease burden falls and where research investment flows across Africa. Interpretation is limited by reliance on ClinicalTrials.gov alone, which may undercount locally registered African studies.
Question

In the burden-versus-investment landscape of African health research, does the distribution of depression trials across African nations reveal a systematic research gap?

Dataset

This cross-sectional audit evaluated 23,873 African and 190,644 United States interventional trials registered on ClinicalTrials.

Method

gov through April 2026.

Primary Result

Investigators computed the Shannon entropy of trial allocation as the primary estimand using registry metadata for each nation.

Robustness

Africa hosted 145 depression trials (0.

Interpretation

6% of its portfolio) compared to 9,503 in the United States, yielding a 0.

Boundary

0-fold disparity in per-population investment.

Extra

Shannon entropy of the trial distribution was 2.

Extra

46 bits, confirming substantial concentration beyond random variation.

Extra

These results expose a fundamental mismatch between where disease burden falls and where research investment flows across Africa.

Extra

Interpretation is limited by reliance on ClinicalTrials.

Extra

gov alone, which may undercount locally registered African studies.